Femasys is trading at $2.69 (+6.32%), amid a generally risk-on market backdrop.
- No new company-specific announcement dated September 21β22, 2026, was identified.
- The latest notable update was September 15, when Minnesota Womenβs Care adopted FemVue and FemaSeed across four locations.
- Major-index gains were mixed, with Nasdaq up 0.48%; no definitive catalyst directly explains the September 22 move.